Product Images Fulvestrant
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 18 images provide visual information about the product associated with Fulvestrant NDC 71288-555 by Meitheal Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - ful08 0004 01
This text is a simple instruction on how to remove a twist-off cap. It advises the user to rotate the cap in a counter-clockwise direction until it disconnects from the bottle.*
Figure 2 - ful08 0004 02
Figure 3 - ful08 0004 03
Figure 4 - ful08 0004 04
Figure 5 - ful08 0004 05
Structural Formula - ful08 0004 06
Figure 6 - ful08 0004 07
This appears to be a chart showing the progression-free survival of two treatments (g1 Fuosirant250 mg and 08 Fulvestrant 500 mg) over a span of 45 months. The x-axis measures time in months and the y-axis displays the number of participants who remain in the study. The chart tracks the number of individuals at risk over time for each treatment. The number of patients in the Fuosirant250 mg group decreases slowly over the course of the treatment, while the number of patients in the Fulvestrant 500 mg group gradually declines to a greater extent.*
Figure 7 - ful08 0004 08
This is a graph showing the proportion of patients alive over a period of 80 months for two different doses of Fulvestrant Injection (500mg and 250mg). The number of patients at risk is also provided for each dose at different time points. Some observations were censored. However, the graph notes that no statistical adjustments were made for multiphicity.*
Figure 8 - ful08 0004 09
Figure 9 - ful08 0004 10
The text describes a graph showing the Progression-Free Survival Probability for patients (represented vertically) over time (represented horizontally in months). The data is divided by treatments with Fulvestrant Injections and Fulvestrant Injections with Palbociclib, compared to Placebo treatment. The number of patients at risk for each treatment at different times is also shown. The text also includes abbreviations: FUL stands for Fulvestrant Injection and PAL stands for palbociclib, and PCB stands for Placebo.*
Figure 10 - ful08 0004 11
This is a survival probability graph displaying the number of patients at risk over time (in months) for two groups treated with Fulvestrant injections, one with palbociclib and the other with a placebo. The graph shows the overall survival probability for each group.*
Figure 11 - ful08 0004 12
Figure 12 - ful08 0004 13
The text appears to be a chart or table showing the number of censored observations and different treatment groups in a study involving Fulvestrant Injection combined with either Abemaciciib or Placebo. The chart also shows a timeline in months. However, the output contains errors and non-English characters which make it difficult to interpret accurately.*
Figure 13 - ful08 0004 14
Figure 14 - ful08 0004 15
meitheal Logo - ful08 0004 16
Principal Display Panel – Fulvestrant Injection, 250 mg per 5 mL (50mg per ml) Syringe Label - ful08 0004 17
The text is a description of a medication named Fulvestrant Injection. The NDC (National Drug Code) of the medication is 71288-555-85 Bty. The medication is for intramuscular use only, containing 250mg per 5mL (50mg per mL). The administered site, site date, and the information about the administrator is mentioned. It is also advised to shake the medication before using it.*
Principal Display Panel – Fulvestrant Injection, 250 mg per 5 mL (50mg per ml) Carton - ful08 0004 18
Fulvestrant Injection is a medication that is given intramuscularly through prefilled syringes. Each carton contains two single-dose syringes, each having 250 mg of medicine. To get a 500 mg dose, both syringes must be administered. Before use, discard the syringe. The drug comes in a carton with NDC number 71268-555-86.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.